A disabling mosquito-borne disease called chikungunya has killed two elderly people in the French Indian Ocean island of La ...

The chikungunya virus virus-like particle vaccine is well tolerated and shows high immunogenicity in both previous recipients ...

The chikungunya vaccination is recommended for those traveling to areas where there is a chikungunya outbreak.

Scientists at IIT Roorkee have achieved a major breakthrough by identifying a potential drug for the treatment of chikungunya ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

Sri Lanka is experiencing a rapid spread of Chikungunya, a mosquito-borne viral disease, with cases reported from various ...

The IIT Roorkee study on Efavirenz offers a new avenue for Chikungunya treatment, bringing optimism to patients and doctors ...

The vaccine, approved in November 2023, is recommended for adults traveling somewhere with a chikungunya outbreak. Chikungunya is a mosquito-borne disease that causes fever and joint pain.

Taking proper precautions can significantly reduce the risk of infections, keep reading as we share some tips.

IIT Roorkee researchers have discovered that Efavirenz, an HIV drug, may help treat Chikungunya by reducing virus replication in lab tests and mice models. While promising, clinical trials are needed ...

A mosquito-borne disease called chikungunya has killed two elderly people on France's Reunion Island, local authorities said ...

Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscular as a single 0.8mL dose. Vimkunya ™ (chikungunya vaccine, recombinant) is now available in the US for ...